Brief: Aesther Healthcare Acquisition - discovery of bispecific antibodies and immune checkpoint inhibitors that kill glioblastoma cells and melanoma cells
06/09/2022 13:01
Sept 6 (Reuters) - Aesther Healthcare Acquisition Corp
AEHA.O :
* AESTHER HEALTHCARE ACQUISITION - DISCOVERY OF BISPECIFIC
ANTIBODIES AND IMMUNE CHECKPOINT INHIBITORS THAT KILL
GLIOBLASTOMA CELLS AND MELANOMA CELLS
Source text for Eikon: ID:nGNX5F1T9B
Further company coverage: AEHA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26